Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders: Proceedings of the Round Table Conference. Rome, October 30 – 31, 1974

Introductory Remarks.- Methodology and Physiology Chairmen: G.V.R. Born and K. Breddin.- The Platelet as an Inflammatory Cell.- Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders.- The Mathematical Analysis of the Human Platelet Aggregation Mechanism and Its Clinical Application.- Quantitative Valuation of Platelet Aggregation Curves through the Calculation of a Numerical Index.- The Polyunsaturated Fatty Acids in Human Platelets: Effects of Diet and Possible Functional Significance.- Enhanced Platelet Aggregation as a Risk Factor for Progress and Complications of Vascular Disease. New Findings with a Platelet Aggregation Test (PAT III) and on the Dependence of Different Aggregation Tests on Morphologic Platelet Changes.- Pathogenesis Chairmen: M. Anthony, T. Abe, E.J. Acheson, J.S. Meyer, J. Marshall, K.J. Zülch.- Thrombosis and Embolism as a Cause of Ischemic Cerebrovascular Disturbances. Analysis from a Series of 1000 Patients.- Platelet Adhesiveness and Cerebral Vascular Disease Revisited.- The Significance of Platelet Aggregation in Amaurosis Fugax.- Mechanisms of Platelet 5-Hydroxytryptamine Release in Migraine.- Experimental observations on Platelet Emboli in Focal Brain Ischemia.- Observations on Platelet Aggregability in the Acute Phase of Untreated Strokes.- Microembolism in the Nervous System.- Influence of Plasma Components in the Development of Conditions of Increased Platelet Aggregation Found in a Number of Vascular Diseases.- Mechanism Associated with Platelet Adhesiveness in Cerebrovascular Disease.- Regional Intravascular Coagulation and Microthrombosis in Traumatic Brain Lacerations in Man.- Platelet Aggregation in Cerebrovascular Patients.- In Vivo Effect of Cyclic AMP and Related Drugs on Platelet Function.- Platelet Hyperreactivity and Decreased Survival in Chronic Cerebrovascular Patients. Chronic Defibrination Syndrome?.- Arterial Hypertension and Platelet Aggregation in the Patho-Pathogenesis of Cerebrovascular Diseases.- Smoking, Cerebrovascular Diseases and Platelet Functions.- Contribution of Platelet Aggregation and Serotonin Release to Progressive Cerebral Infarction.- Effect of Agents which Modify Platelet Aggregation and/or Coagulation on Experimental Platelet Embolism and Intravascular Coagulation.- Platelet Abnormalities in Cerebrovascular Diseases.- Inhibition of Platelet Aggregation by Synthetic Organic Acids: Quantitative Relationships Between Chemical Structures and Biological Activities.- Some Observations of Platelet Changes in Atherosclerosis and Some Observations in the Platelet Alterations Before and After Antiaggregant Drugs in Normal and Atherosclerotics.- Pharmacology and Clinical Pharmacology Chairmen: C.A. Bouvier, W.S. Fields, O.N. Ulutin, A. Rascol.- Inhibition of Platelet Thrombus Formation by Pharmacological Agents.- A Long-Term Clinical Trial with Antiplatelet Agents in Cerebrovascular Ischemia: Biological and Methodological Aspects.- Effect of Aspirin and Dipyridamole on Platelet Function and on Neurologic Evaluation of Patients Affected by Stroke or Transient Ischemic Attacks.- The Pharmacologic Control of the Enhanced Platelet Aggregation in Preventive Neurology.- Aspirin in Cerebral Ischemia.- The Canadian Cooperative Studies of the Effect of Platelet-Suppressing Drugs in Transient Cerebral Ischemic Attacks.- On the Relationships Between the Activation of the Complement System and the Platelet Aggregation.- Discussion and Concluding Remarks.- Chairmen’s Considerations.- Concluding Remarks.